Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann N Y Acad Sci. 2003 Sep;998:473-80.

Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy.

Author information

1
Department of Neurology, University of Texas Southwestern Medical School, Dallas, Texas 75390-8897, USA. gil.wolfe@utsouthwestern.edu

Abstract

Thymectomy has been regularly used in the management of nonthymomatous autoimmune myasthenia gravis (MG), but its benefits have not been established in a randomized, controlled trial. The widespread use of thymectomy in MG patients without thymoma is largely based on retrospective, nonrandomized case series that have produced a consensus that the procedure is sometimes beneficial. Still, the benefits and utilization of thymectomy are actively debated among MG experts. In this paper, we describe the development of a multicenter, international trial to determine whether extended transsternal thymectomy reduces corticosteroid requirements for patients with generalized AChR antibody-positive nonthymomatous MG.

PMID:
14592916
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center